Table 1.
Patients' demographical, laboratory, and predictive characteristics and results.
| Subjects N = 9 |
|
|---|---|
| Age, years | 71 ± 10 |
| Men (%) | 5 (56) |
| Body-mass-index (kg/m2) | 27.4 ± 2.9 |
| Hypertension (%) | 7 (78) |
| Diabetes mellitus (%) | |
| Insulin therapy | 1 (11) |
| Oral antidiabetics | 3 (33) |
| Congestive heart failure (%) | 6 (67) |
| Prior coronary artery disease (%) | 7 (78) |
| Applied contrast agent (mL) | 81.7 ± 57.3 |
| Attempted approach | 129.0 (array: 71.6–304.9) |
| Delivered approach | 81.7 (array: 45.5–211.9) |
| Baseline eGFR (MDRD; mL/min/1.73 m2) | 71.5 ± 9.4 |
| Baseline eGFR (CKD-EPI; mL/min/1.73 m2) | 67.8 ± 10.3 |
| Baseline serum creatinine (mg/dL) | 1.15 ± 0.36 |
| Baseline hemoglobin (g/dL) | 12.5 ± 2.3 |
| Ratio of total contrast volume/baseline CG-creatinine clearance | |
| Attempted approach | 1.84 (array: 1.03–4.41) |
| Delivered approach | 1.12 (array: 0.73–3.04) |
| Mehran's Integer CI-AKI Risk Score (score points) | 8 (array: 4–13) |
| ≤5 (low-risk) | 1 (11) |
| 6–10 (moderate-risk) | 6 (67) |
| 11–15 (high-risk) | 2 (22) |
| ≥16 (very high-risk) | 0 (0) |
Data are presented as mean ± SD if not otherwise labeled. CI-AKI = contrast-induced acute kidney injury; eGFR = estimated glomerular filtration rate; CG = Cockcroft–Gault formula.